Search
The Turkish medical device market has seen significant and consistent growth over the past decade. In 2021, Turkey adopted the EU Medical Devices Regulation (MDR) 2017/745 and In Vitro Diagnostics Medical Devices Regulation (IVDR) 2017/746. This enhanced international trade leading several global companies to launch their medical devices in the country.
Regulatory Authority: Turkish Medicines and Medical Devices Agency (TITCK)
Regulation: Medical Device Regulations (MDR) 2017/745, In Vitro Diagnostic Devices Regulations 2017/746
Regulatory Pathway: CE marking is mandatory followed by Registration/Notification in the Product Tracking System (UTS)
Authorized Representative: European Authorized Representative (EAR) for foreign (non-EU/non-Turkey) manufacturers
QMS Requirement: ISO 13485:2016
Assessment of Technical Data: Notified Body for CE marking
Validity of License: Unlimited
Submission Format: Paper
Translation: Translated Documents in Turkish
Turkey follows the same medical device classification as given in the EU MDR and IVDR. Determining the device classification can be challenging and hence having backed by an experienced regulatory consultant is quite crucial here.
Class |
Risk |
Class I |
Low |
Class IIa |
Moderate |
Class IIb |
Moderate to High |
Class III |
High |
Class |
Risk |
Class A |
Low |
Class B |
Moderate |
Class C |
Moderate to High |
Class D |
High |
Now, due to the custom union agreement, the EU manufacturers do not require to appoint a local authorised representative to place their devices in the market.
Other foreign manufacturers are required to appoint a European Authorised Representative (EAR) to place the devices in the Turkey market.
CE marking is a conformity that is required by the manufacturers to place their device in the Turkey market. CE marking is issued through a conformity assessment carried out by the notified body. Now, Turkey is authorised to appoint notified bodies in accordance with EU MDR and IVDR.
The companies are required to register in Central Registration System (MERSIS) registration and register the device in the Product Tracking System (UTS).
Freyr supports foreign manufacturers in end-to-end Medical Device lifecycle management, including post-approval activities, such as:
With various authorization bodies involved, foreign manufacturers need to comply with multiple sets of regulations in each individual process for device approvals. Obtaining a CE marking and further adhering to state-wise regulations needs extensive Regulatory knowledge. At times, without a proven Regulatory partner, navigating through all the device requirements might be challenging for market entrants. To assist manufacturers, Freyr provides end-to-end Regulatory services to expedite approvals for medical devices.
Our Newsletter